tbuckley/cabot-search huggingface dataset:
Simple Preservation of Single Cells (SENSE): One-Step Robust Whole Blood Cryopreservation Method Enables the Generation of High-Quality Single-Cell Immune Profiles
Authors: Sarthak Satpathy, Beena Thomas, William Pilcher, Mojtaba Bakhtiari, Lori A. Ponder, Rafal Pacholczyk, Sampath Prahalad, Swati Bhasin, David H. Munn, Manoj Bhasin
Journal: Blood (2023)
Results of the Phase II of Epirchop Study, Evaluating the Efficacy of Tazemetostat in Combination with R-CHOP in Elderly Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL): A Lysa Study
Authors: Clementine Sarkozy, Thierry Jo Molina, Roch Houot, Sydney Dubois, Gian Matteo Pica, Philippe Ruminy, Charles Herbaux, Thomas Gastinne, Corinne Haioun, Stephanie Guidez, Christophe Bonnet, Marc Andre, Liana Vereseza, Choquet Sylvain, Loic Ysebaert, Emmanuel Bachy, Fabrice Jardin, Franck Morschhauser, Vincent Ribrag
Journal: Blood (2023)
Radiotherapy Consolidation Reduces Risk of Relapse in Diffuse Large B-Cell Lymphoma Patients with Bulky Disease in Complete Response after Frontline Immunochemotherapy: Results from a Retrospective Single Center Study
Authors: Corrado Benevolo Savelli, Mattia Novo, Francesco Vassallo, Andrea Evangelista, Matteo Bisio, Luca Legato, Veronica Peri, Michele Clerico, Mario Levis, Sara Bartoncini, Chiara Cavallin, Maura Nicolosi, Carola Boccomini, Lorella Orsucci, Federica Cavallo, Benedetto Bruno, Roberto Freilone, Umberto Ricardi, Barbara Botto
Journal: Blood (2023)
Do the Control Cohorts of Phase III Randomized Trials Reflect the Real-World Results of DLBCL Patients?
Authors: Prokop Vodicka, Andrea Janikova, David Belada, Heidi Mocikova, Vit Prochazka, Juraj Duras, Katerina Steinerova, Vit Campr, Katerina Benesova, Samuel Hricko, Alice Sykorova, Petra Blahovcova, Radek Jaksa, Magdalena Klanova, Marek Trněný
Journal: Blood (2023)
Comparison of Biosimilar Filgrastim (Nivestym) Versus Originator Filgrastim (Neupogen) for Peripheral Blood Stem Cell Mobilization for Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Moazzam Shahzad, Joe S. Al-Ramahi, Muhammad Kashif Amin, Muhammad Fareed Khalid, Shaun DeJarnette, Zahra Mahmoudjafari, Maggie Nelson, Riley Hastings, Haitham Abdelhakim, Forat Lutfi, Nausheen Ahmed, Rajat Bansal, Leyla Shune, Al-Ola Abdallah, Anurag K. Singh, Sunil Abhyankar, Joseph P McGuirk, Muhammad Umair Mushtaq
Journal: Blood (2023)
Clinical Outcomes and Mutational Profile Associated with Dysmyelopoiesis in Chronic Myelomonocytic Leukemia
Authors: Xavier Calvo, David Román, Nieves Garcia Garcia-Gisbert, Concepción Fernández-Rodriguez, Marta Salido, Anna Puiggros, Blanca Espinet, Sara Garcia-Avila, Félix López Cadenas, Abora Rial-Villavecchia, Luis Colomo, Lourdes Florensa, Ana Ferrer, Leonor Arenillas
Journal: Blood (2023)
Interferon-Alpha Impairs Neoplastic Vasculogenesis in a 3D iPSC-Based Model of JAK2V617F+ Myeloproliferative Neoplasms
Authors: Madeline J. Caduc, Martin Grasshoff, Sabrina Ernst, Gerhard Müller-Newen, Jörg Eschweiler, Ivan G. Costa, Tim H. Brümmendorf, Steffen Koschmieder, Marcelo Szymanski de Toledo
Journal: Blood (2023)
Next-Generation Sequencing (NGS) for Residual Disease (MRD) Monitoring in T-Lymphoblastic Leukemia (T-ALL)
Authors: Ntasha Roy, Zhengwei (Jenny) Mao, Chang Xu, David T. Teachey, Zhiguo (Bruce) Chen, Meenakshi Devidas, Xueyan Chen, Elizabeth A. Raetz, Mignon L. Loh, Stephen P. Hunger, Brent L. Wood
Journal: Blood (2023)
Application of State Transition Theory and Treatment Modeling for Predicting Response to Chemotherapy in a Mouse Model of Acute Myeloid Leukemia
Authors: Lisa Uechi, Yu-Hsuan Fu, David Frankhouser, Denis O'Meally, Sergio Branciamore, Lianjun Zhang, Man Li, Guido Marcucci, Russell C. Rockne, Ya-Huei Kuo
Journal: Blood (2023)
Tumor-Infiltrating Normal B Lymphocytes Have Remarkable Prognostic Effects and Are Crucial for Antitumor Immune Responses in Diffuse Large B-Cell Lymphoma
Authors: Zijun Y. Xu-Monette, Yong Li, Thomas Snyder, Tiantian Yu, Tingxun LU, Alexandar Tzankov, Carlo Visco, Govind Bhagat, Wenbin Qian, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, Frederick Hagemeister, Heounjeong Go, Maurilio Ponzoni, Andrés José María Ferreri, Michael Møller, Benjamin M. Parsons, Joannes H.J.M. Van Krieken, Yingjun Wang, Miguel Angel Piris, Jane Winter, Qingyan Au, Ilan Kirsch, Mingzhi Zhang, John D Shaughnessy, Jr, Bing Xu, Ken H. Young
Journal: Blood (2023)
Potential Predictive Biomarkers for the Development and Outcomes of Inhibitors in Hemophilia A Patients
Authors: Meng-Ni Fan, Tangliang Shen, Xiaohe Cai, Ting-Yen Chao, Marilyn Manco-Johnson, Weidong Xiao, Barbara A. Konkle, Lei Li, Carol H. Miao
Journal: Blood (2023)
Distinct Minor Neoplastic Follicular T-Cell Subsets Dictate Lymphoma Fates through Functional Specialization
Authors: Yoshiaki Abe, Junko Zenkoh, Daisuke Ikeda, Sawa Aya, Daisuke Kaji, Rikako Tabata, Ryota Matsuoka, Manabu Fujisawa, Kenichi Makishima, Sakurako Suma, Keiichiro Hattori, Yasuhito Suehara, Tatsuhiro Sakamoto, Chikashi Yoshida, Hiroko Bando, Ayako Suzuki, Yasunori Ota, Yoshihito Otsuka, Kosei Matsue, Shigeru Chiba, Yutaka Suzuki, Mamiko Sakata-Yanagimoto
Journal: Blood (2023)
Remodeling of the Immune Microenvironment By Oncogenic MYD88 Dictates Immunotherapy Responses across Indolent and Aggressive B-Cell Lymphomas
Authors: Jon Celay, Miriam Recalde, María Victoria Revuelta, Marta Larrayoz, Sara Rodriguez, Maria J Garcia-Barchino, Jennifer R. Chapman-Fredricks, Teresa Lozano, Juan J Lasarte, Ming Q. Du, Izidore S. Lossos, Sergio Roa, Aldo Roccaro, Miguel Canales, Felipe Prosper, Bruno Paiva, Leandro Cerchietti, Jose A. Martinez-Climent
Journal: Blood (2023)
Outcomes in Chemotherapy-Ineligible Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax Plus Azacitidine: A Pooled Analysis
Authors: Adriano Venditti, Jing-Zhou Hou, Pierre Fenaux, Brian A. Jonas, Radovan Vrhovac, Pau Montesinos, Jacqueline S. Garcia, David Rizzieri, Michael J Thirman, Stanley Kotey, Jalaja Potluri, Mazaher Dhalla, Vinod Pullarkat
Journal: Blood (2023)
<i>Dnmt3a</i>-Mutant Haematopoietic Stem and Progenitor Cells Induce Mesenchymal Stromal Cell Senescence through the Production of Alarmins S100A8/A9
Authors: Jayna J. Mistry, Kira A. Young, Patricia Colom Diaz, Ines Fernandez Maestre, Ross L Levine, Jennifer J. Trowbridge
Journal: Blood (2023)
All-Cause Mortality after Major Gastrointestinal Bleeding Among Patients Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis
Authors: Nicholas L.J. Chornenki, Roupen Odabashiain, Jenneke Lenteejens, Fabian Stucki, Tobias Tritschler, Deborah Siegal
Journal: Blood (2023)
Venetoclax Combining with Homoharringtonine，Daunorubicin and Cytarabine (HAD) As Induction Treatment in Newly Diagnosed Adult Acute Myeloid Leukemia Patients
Authors: Zhangsong Yan, Yang Li, Bin Zhang, Jinsong He, Jiesi Li, Shuning Wei, Qi Wang, Qiuling Li, Bo Hu, Kaiqi Liu, Yingchang Mi
Journal: Blood (2023)
Chidamide-Based Pre-Emptive Treatment for High-Risk AML Patients after Hematopoietic Stem Cell Transplantation: A Real-World Experience from Chinese Single-Center
Authors: Ping Wu, Wei Ling, Chengwei Luo, Xiaomei Chen, Lisi Huang, Jinghua Wang, Peilong Lai, Suijing Wu, Xin Du, Jianyu Weng
Journal: Blood (2023)
Hydroxyurea Improves Intelligence Quotient Scores in Children with Sickle Cell Anemia and Elevated Transcranial Doppler Velocity
Authors: Angela E Rankine-Mullings, Deanne Soares, Karen Aldred, Susan Chang-Lopez, Margaret Elizabeth Wisdom-Phipps, William Schultz, Teresa S. Latham, Susan E. Stuber, Patrice Jackson, Russell E. Ware, Marvin Ellsworth Reid
Journal: Blood (2023)
Prospective Pharmacokinetic Evaluation of Venetoclax (VEN) in AML Demonstrates Significant and Variable Drug Interactions with Azole Antifungals That Increase Ven Exposure, Reduce Clearance, and Necessitate Re-Evaluation of Dose Adjustments
Authors: Jitesh Kawedia, Caitlin R Rausch, Xiaoqian Li, Courtney D. DiNardo, Farhad Ravandi, Naval Daver, Gautam Borthakur, Naveen Pemmaraju, Patrick K Reville, Nicholas J. Short, Elias Jabbour, Guillermo Garcia-Manero, Hagop M. Kantarjian, Tapan M. Kadia
Journal: Blood (2023)
Pivekimab Sunirine (PVEK, IMGN632), a CD123-Targeting Antibody-Drug Conjugate, in Combination with Azacitidine and Venetoclax in Patients with Newly Diagnosed Acute Myeloid Leukemia
Authors: Naval Daver, Pau Montesinos, Jessica K. Altman, Eunice S. Wang, Giovanni Martinelli, Gail J. Roboz, Kebede Begna, Paresh Vyas, Monia Lunghi, Uwe Platzbecker, Patrick W. Burke, Roland B. Walter, Anjali S. Advani, Sylvain Garciaz, Lauris Gastaud, David A Sallman, Naveen Pemmaraju, Laura Torres, Yasmin Abaza, Onyee Chan, Hagop M. Kantarjian, Benjamin Oshrine, Yining Du, Kara Malcolm, Kendra Sweet
Journal: Blood (2023)
Compared to Venetoclax Plus Hypomethylating Agents, High Dose Cytarabine Based Intensive Chemotherapy Induction for Newly Diagnosed Acute Myeloid Leukemia (AML) Leads to a Faster Remission Resulting in Better Survival
Authors: Melhem M. Solh, Scott R. Solomon, Lawrence Morris, H Kent Holland, Lizamarie Bachier-Rodriguez, Xu Zhang, Katelin C Jackson, Asad Bashey
Journal: Blood (2023)
A First-in-Human Phase 1 Trial of NX-2127, a First-in-Class Bruton's Tyrosine Kinase (BTK) Dual-Targeted Protein Degrader with Immunomodulatory Activity, in Patients with Relapsed/Refractory B Cell Malignancies
Authors: Alexey Danilov, Michael T. Tees, Krish Patel, William G. Wierda, Manish Patel, Ian W. Flinn, Tahir Latif, Weiyun Ai, Meghan C. Thompson, Michael L. Wang, Clare Sun, Deborah M. Stephens, Michael J Thirman, Melissa Gessner, Johannes Wolff, Amanda Schwab, May Tan, Daniel Chan, Erin Meredith, Adrian Wiestner
Journal: Blood (2023)
Ibrutinib Added to Standard Conditioning and As Consolidation Therapy Following Autologous Hematopoietic Stem Cell Transplantation (AutoHCT) for Relapsed/Refractory Activated-B-Cell Subtype Diffuse Large B-Cell Lymphoma (ABC-DLBCL): Primary Analysis of the US Intergroup Double-Blind Randomized Phase III Study Alliance A051301/BMT-CTN 1201
Authors: Charalambos Andreadis, Olivia Bobek, Eric D. Hsi, Timothy S. Fenske, Susan M. Geyer, Patrick J. Stiff, Brian T. Hill, Mitchell Horwitz, Farhad Khimani, Richard F. Little, Shira N. Dinner, Jonathan W. Friedberg, Brad S. Kahl, Miguel-Angel Perales, Steven M. Devine, John P. Leonard, Nancy L. Bartlett
Journal: Blood (2023)
A Prospective Phase II Clinical Study of Low-Frequency Daratumumab for the Treatment of Systemic Light Chain Amyloidosis
Authors: Donghua He, Xinyi Meng, Jingsong He, Wenjun Wu, Jinuo Wang, Chunting Zhu, Xiaoyan Han, Yi Zhao, Gaofeng Zheng, Yi Li, Xing Guo, Qingxiao Chen, Fangshu Guan, Zhen Cai
Journal: Blood (2023)
EZH2 Inhibitors Enhance CART Cell Quality, Efficacy, In Vivo Homing, Tumor Cell Binding and Killing of Fully Syngeneic Primary B Cell Lymphomas, As Well As Reprogramming Lymphoma Cells to a Highly Immunogenic and T Cell Adherent Phenotype
Authors: Yusuke Isshiki, Patrizia Porazzi, Xi Chen, Matthew Teater, Ioannis Karagiannidis, Henna S. Nam, Ari M Melnick, Marco Ruella, Wendy BÃ©guelin
Journal: Blood (2023)
Real-World Use of Recombinant Von Willebrand Factor in People with Clinically Severe Congenital Von Willebrand Disease: Interim Analysis of Athn 9: A Natural History Study for People with Severe VWD
Authors: Robert F. Sidonio, Angela C Weyand, Tammuella Chrisentery-Singleton, Martin Chandler, Haduwa Momoh, Priscilla Driscoll-Shempp, Bethany Jones, Natalia Nieto, Jorge Caicedo
Journal: Blood (2023)
Antifungal Prophylaxis in Newly Diagnosed Acute Myeloid Leukemia Treated with a Hypomethylating Agent and Venetoclax: A Real-World Experience in Pharmacovigilance
Authors: Mary Burke, David A Sallman, Ariel Denson, Rebecca Jean Nelson, Onyee Chan, Alison R. Walker, Eric Padron, Zhuoer Xie, Rami S. Komrokji, Jeffrey Lancet, Andrew T. Kuykendall, Katherine Tobon, Akriti Gupta Jain, Chen Wang, Najla H Al Ali
Journal: Blood (2023)
Impact of 1q21 Gain and Amplification on Daratumumab-Treated Multiple Myeloma Patients: Real-World Data from the Australia-New Zealand and Asia-Pacific Myeloma and Related Diseases Registries
Authors: Kenneth J C Lim, Cameron Wellard, Elizabeth Moore, Slavisa Ninkovic, Wee-Joo Chng, Andrew Spencer, Peter Mollee, Jay Hocking, Phoebe Joy Ho, Wojt Janowski, Kihyun Kim, Karen Dun, Zoe K McQuilten, Fiona Chen, Hang Quach
Journal: Blood (2023)
Decitabine/Cedazuridine (ASTX727) Combined with a Molecularly-Targeted Agent (Venetoclax, Gilteritinib, Ivosidenib, or Enasidenib) As Personalized Maintenance Therapy in Acute Myeloid Leukemia: First Results from a Phase 1b Study
Authors: Alexandre Bazinet, Hagop M. Kantarjian, Farhad Ravandi, Nicholas J. Short, Naval Daver, Maro Ohanian, Musa Yilmaz, Kelly S. Chien, Abhishek Maiti, Courtney D. DiNardo, Jo Ishizawa, Lucia Masarova, Debra Bull-Linderman, Gautam Borthakur, Elias Jabbour, Guillermo Garcia-Manero, Tapan M. Kadia
Journal: Blood (2023)
Loss of p53 Impairs Death Receptor Expression and Confers Resistance to CD19-Directed CAR T-Cell Therapy in B-Cell Precursor Acute Lymphoblastic Leukemia
Authors: Willem P. J. Cox, Noel M. M. Dautzenberg, Linde Dekker, Tesa Klenovšek, Marliek van Hoesel, Gawin R. Stoll, Roland P. Kuiper, Laurens T. van der Meer, Friso G. J. Calkoen, Stefan Nierkens, Frank N. van Leeuwen
Journal: Blood (2023)
Early and Consistent CRS Detection Using Wearable Device for Remote Patient Monitoring Following CAR-T Therapy in Relapsed/Refractory Multiple Myeloma (RRMM): Early Results of an Investigator-Initiated Trial
Authors: Sridevi Rajeeve, Nicole Zahradka, Matt Wilkes, Darren Pan, Nicholas J Calafat, Kseniya Serebryakova, Katerina Kappes, Hayley Jackson, Nicole Buchenholz, Sarita Agte, Santiago Thibaud, Larysa Sanchez, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Hearn Jay Cho, Ajai Chari, Sundar Jagannath, Adriana C Rossi, Samir Parekh
Journal: Blood (2023)
Beyond MIPI: Harnessing Machine Learning and Histological Subtype for Enhanced MCL Prognostication of Survival
Authors: Adrian Mosquera Orgueira, Alba Carbita, Victor Navarro Garces, Pau Abrisqueta, Rodrigo Alonso Salcedo Pereda, Carlos Aliste Santos, Marta Canelo Vilaseca, Marina Gomez Rosa, Alberto Lopez Garcia, Tomas Garcia, Fatima De la Cruz, Juan-Manuel Sancho, Eduardo Rios Herranz, Raul Cordoba, Angel Serna, Gloria Iacoboni, Moraima Jiménez, Cecilia Carpio, Cristina Garcia, Josep Castellvi, Francesc Bosch, Ana Marin Niebla
Journal: Blood (2023)
Whole Exome Sequencing of Patients with Adult-Onset Evans Syndrome: A Cohort of 80 Patients
Authors: Etienne Crickx, Jehane Fadlallah, Morgane Cheminant, Jeremie Rosain, Jeremie Dion, Marion Malphettes, David Boutboul, Clement Gourguechon, Mikael Ebbo, Anne Marie Ronchetti, Thomas Moulinet, Delphine Gobert, Jerome Hadjadj, Julie Graveleau, Marie-Claude Stolzenberg, Bertrand Godeau, Lionel Galicier, Jean-Francois Viallard, Sylvain Audia, Eric Oksenhendler, Claire Fieschi, Olivier Hermine, Matthieu Mahevas, Marc Michel, Frédéric Rieux Laucat
Journal: Blood (2023)
Olutasidenib for the Treatment of mIDH1 Acute Myeloid Leukemia in Patients Relapsed or Refractory to Hematopoietic Stem Cell Transplant, Prior mIDH1 Inhibitor, or Venetoclax
Authors: Jorge Cortes, Joseph Jurcic, Maria R. Baer, William Blum, P. Brent Ferrell, Brian A. Jonas, Sangmin Lee, Alice Mims, Shyam Ajay Patel, Gary J. Schiller, Jay Yang, Justin M. Watts
Journal: Blood (2023)
Oligomannose-Type Glycans in the Antigen Binding Site Identify Origin and Prognosis of Diffuse Large B Cell Lymphoma
Authors: Dylan J. Tatterton, Benjamin Sale, Joel Allen, Maddy L. Newby, Giorgia Chiodin, Patrick J. Duriez, John Butler, Katy J. McCann, David W. Scott, Ryan Morin, Andrew S. Davies, Dean J. Bryant, Freda K. Stevenson, Max Crispin, Francesco Forconi
Journal: Blood (2023)
Fitusiran Population Pharmacokinetic and Pharmacodynamic Modeling Utilizing Phase 3 Clinical Trial Data to Confirm Doses Tested in Phase 3 Trials to Support an Antithrombin-Based Dose Regimen
Authors: Kumpal Madrasi, Pratik Bhagunde, Sajida Iqbal, Marja Puurunen, Marek Demissie, Shauna Andersson, Sreeraj Macha, Malidi Ahamadi
Journal: Blood (2023)
R-GemOx Plus Nivolumab Vs R-GemOx As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Interim Analysis of the Niveau Trial, an International, Randomized Phase 3 Study of the AGMT, GLA, HOVON, Lysa and PLRG
Authors: Gerhard Held, Bettina Altmann, Andrea Kerkhoff, Thomas Gastinne, Thomas Weber, Rene-Olivier Casasnovas, Hervé Tilly, Maria Gomes Da Silva, Jörg Hoffmann, Sanne Tonino, Stéphane Vigouroux, Martin Dreyling, Violaine Safar, Marc Andre, Stephanie Mayer, Franck Morschhauser, Pierre Feugier, Christian W. Scholz, Anna Dabrowska-Iwanicka, Philippe Gaulard, Thierry Jo Molina, Andreas Rosenwald, Richard Greil, Ulrich Jaeger, Abraham Avigdor, Lorenz Thurner, Stephanie Maurer, Markus Löffler, Marita Ziepert, Corinne Haioun, Viola Poeschel, Roch Houot
Journal: Blood (2023)
Comparison of Various Stem Cell Mobilization Regimens for Multiple Myeloma - a 15-Year Retrospective Institutional Analysis from India
Authors: Sumeet Mirgh, Bhausaheb Bagal, Sachin Punatar, Anant Gokarn, Nishant Jindal, Akanksha Chichra, Lingaraj Nayak, Laxma Reddy, Sumathi Hiregoudar, Minal Poojary, Suryatapa Saha, Shashank Ojha, Sarika Parab, Prashant Tembhare, Nikhil Patkar, Gaurav Chatterjee, Sweta Rajpal, Libin Jacob Mathew, Papagudi Ganesan Subramanian, Hari Menon, Navin Khattry
Journal: Blood (2023)
The Proliferative History Index, Epicmit, Derived from Genome-Wide Epigenomic Profiling, Is a Key Driver of Clinical Survival in Splenic Marginal Zone Lymphoma
Authors: Helen Parker, Amatta Mirandari, Carolina Jaramillo-Oquendo, Marti Duran-Ferrer, Ben Stevens, Lara Buermann, Harindra Eranthi Amarasinghe, Jaya Thomas, Louise J. Carr, Shama Syeda, Methusha Sakthipakan, Marina Parry, Zadie Davies, Neil McIver-Brown, Aliki Xochelli, Sarah Ennis, Lydia Scarfo, Paolo Ghia, Christina H. Kalpadakis, Gerassimos Pangalis, Davide Rossi, Simon Wagner, Matthew Ahearne, Marc Seifert, Christoph Plass, Dieter Weichenhan, Eva Kimby, Lesley Ann Sutton, Richard Rosenquist, Francesco Forconi, Kostas Stamatopoulos, Marta Salido, Ana Ferrer, Catherine Thieblemont, David Graham Oscier, Renata Walewska, Matthew JJ Rose-Zerilli, Jane Gibson, Iñaki I. Martin Subero, Christopher C. Oakes, Dean J. Bryant, Jonathan C. Strefford
Journal: Blood (2023)
Effect of Caplacizumab in the Recovery of ADAMTS13 Level in Patients with Autoimmune Thrombotic Thrombocytopenic Purpura. Analysis from the Spanish Registry (REPTT)
Authors: Maria Eva Mingot, Cristina Izquierdo Pascual, Faustino Garcia-Candel, Jorge Martínez Nieto, José García-Arroba Peinado, Javier De La Rubia, Ines Gomez Segui, Maria Liz Pacielo Coronel, David Valcárcel, Moraima Jiménez Balarezo, Joan Cid, Miquel Lozano, Jose Maria Garcia Gala, Sonia Angos Vazquez, Míriam Vara, Luisa Guerra, Francisca Avila Idrobo, ANA Yurena Oliva Hernandez, Saoia Zalba, Inmaculada Tallon Ruiz, Sandra Ortega Sánchez, Rosa Goterris, Maria Moreno Jimenez, Lourdes Dominguez Acosta, Maria Arraiz Ramirez, Luis Hernández, Elena Flores Ballesteros, Julio Del Rio Garma
Journal: Blood (2023)
Non-T-Depleted Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Patients with Relapsed/Refractory Secondary Versus <i>De Novo</i> AML: A Study from the ALWP/EBMT
Authors: Arnon Nagler, Myriam Labopin, Johanna Tischer, Anna Maria Raiola, Desiree Kunadt, Jan Vydra, Didier Blaise, Simona Sica, Renato Fanin, Julia Winkler, Edouard Forcade, Gwendolyn Van Gorkom, Fabio Ciceri, Mohamad Mohty
Journal: Blood (2023)
Acquisition of 1pLOH-1qGain Is a Frequent Trajectory in Expanding Relapsed/Refractory Myeloma Subclones
Authors: Naser Ansari-Pour, Mohammad Kazeroun, Evie Fitzsimons, Selina J Chavda, Alessandro Lagana, Erin Flynt, Udo Oppermann, Karthik Ramasamy, Kwee Yong, Sarah Gooding, Anjan Thakurta
Journal: Blood (2023)
Spatial Technologies Reveal the Immune Landscape of Pediatric Acute Myeloid Leukemia
Authors: Joost B. Koedijk, Inge Van Der Werf, Marijn A. Vermeulen, Alicia Perzolli, Marta F. Fiocco, Hester A. de Groot-Kruseman, Rubina Moeniralam, Kristina B. Christensen, Henrik Hasle, Stefan Nierkens, Mirjam E. Belderbos, Michel C. Zwaan, Olaf Heidenreich
Journal: Blood (2023)
Optimal Therapeutic Strategies in Relapsed/Refractory AML with Prior Exposure to Venetoclax Based Therapy
Authors: Sawyer Bawek, Prutha Patel, Katy Wang, Kristopher Attwood, Tara Cronin, Melissa Fos, Steven Green, Pamela Jeannette Sung, James E Thompson, Elizabeth A. Griffiths, Eunice S Wang, Amanda C. Przespolewski
Journal: Blood (2023)
131I-Apamistamab Effectively Achieved Durable Responses in Patients with R/R AML Irrespective of the Presence of Multiple High-Risk Factors
Authors: Stuart Seropian, James M. Foran, Boglarka Gyurkocza, Rajneesh Nath, Hannah Choe, Mark R. Litzow, Nebu Koshy, Patrick J. Stiff, Ben K. Tomlinson, Sunil Abhyankar, Sameem Abedin, George Chen, Zaid Al-Kadhimi, Partow Kebriaei, Mitchell Sabloff, Johnnie J. Orozco, Katarzyna Joanna Jamieson, Margarida Magalhaes-Silverman, Koen Van Besien, Michael W. Schuster, Arjun D. Law, Sebastian A. Mayer, Hillard M. Lazarus, Jennifer Spross, Kate L Li, Elaina Haeuber, Madhuri Vusirikala, Akash Nahar, Brenda M. Sandmaier, John Pagel, Sergio A. Giralt, Avinash Desai, Camille N. Abboud
Journal: Blood (2023)
Grndad and Disease Modifying Therapy (DMT): Shifts in Dmt Are Seen at the Adolescent/Young Adult Transition in Sickle Cell Disease in a Multi-Site Prospective Registry
Authors: Sophie Lanzkron, Deepa Manwani, Julie Kanter, Arpan A Sinha, Robin E. Miller, Robert Cronin, Seethal A Jacob, James Harper, Alan Randall Anderson, Marsha Treadwell, Amma T. Owusu-Ansah, Beng R. Fuh, Molly Mandernach, Jahnavi Gollamudi, Suzanne L Saccente, Stephanie A. Fritch Lilla, Melissa McNaull, Dana Marie LeBlanc, Kay Linn Saving, Stephanie H. Guarino, Marisol Betensky, Alice J. Cohen, Ashok B. Raj, Farzana A Sayani, Sanjay J. Shah, Shalu Narang, Bindu Kanathezhath Sathi, John J Strouse, Trisha E. Wong, Ofelia A. Alvarez, Srila Gopal, Jessica Liang, Daniel Semakula, Matthew Chang, Kenneth Rivlin, Sana Saif Ur Rehman, Lisa M Shook, Melissa Frei-Jones, Jane A. Little
Journal: Blood (2023)
PET Radiomics Score Generated By Cross-Combination Approach for Treatment Response and Prognosis Prediction in Primary Gastrointestinal Diffuse Large B-Cell Lymphoma Patients
Authors: Jincheng Zhao, Jian Rong, Yue Teng, Man Chen, Bing Chen, Chong Jiang, Jianxin Chen, Jingyan Xu
Journal: Blood (2023)
A Predictive Scoring System for Therapy Failure of Tyrosine-Kinase Inhibitors in Patients with Chronic-Phase Chronic Myeloid Leukemia
Authors: Xiao-shuai Zhang, Bingcheng Liu, Jian Huang, Xin Du, Yanli Zhang, Na Xu, Xiaoli Liu, Li Weiming, Hai Lin, Huanling Zhu, Yunfan Yang, Ling Pan, Xiao-jun Huang, Qian Jiang
Journal: Blood (2023)
Azacitidine Plus Venetoclax Maintenance in Acute Myeloid Leukemia Produces Sustained Remissions with Low Toxicity: Results of a Phase 2 Study
Authors: Alexandre Bazinet, Hagop M. Kantarjian, Gautam Borthakur, Musa Yilmaz, Prithviraj Bose, Elias Jabbour, Yesid Alvarado Valero, Kelly S. Chien, Naveen Pemmaraju, Koichi Takahashi, Nicholas J. Short, Naval Daver, Ghayas C. Issa, Nitin Jain, Danielle E. Hammond, Debra Bull-Linderman, Courtney D. DiNardo, Jan A. Burger, Alessandra Ferrajoli, Guillermo Montalban-Bravo, Koji Sasaki, Guillermo Garcia-Manero, Farhad Ravandi, Tapan M. Kadia
Journal: Blood (2023)
Validation of Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event-Free Survival in Intermediate and High-Risk Hodgkin Lymphoma
Authors: Lianna J. Marks, Yiwang Zhou, Ying Zheng, Angela Feraco, Alison M. Friedmann, Howard J. Weinstein, Michael P. Link, Jamie E. Flerlage
Journal: Blood (2023)
BCR-ABL1 Dislocates NPM1, PU.1 and KLF1 into Cytoplasm to Thereby Skew Granulo-Monocytic and Impede Erythroid Differentiation
Authors: Zeinab Albadry M. Zahran, Xiaorong Gu, Babal K. Jha, Yogenthiran Saunthararajah
Journal: Blood (2023)
Phase Separation of PML/RARα Microspeckles Governs Transcriptional Dysregulation through Genomic Rewiring of BRD4 in Acute Promyelocytic Leukemia
Authors: Yi Zhang, Kankan Wang, Jiacheng Lou, Yabin Liu, Peng Jin, Yun Tan, Huan Song, Wen Jin, Fangyi Dong, Shishuang Wu, Hai Fang
Journal: Blood (2023)